ArticleBMC nephrology2025
From renal biopsy to genetic diagnosis: EYA1 mutation in branchio-oto-renal syndrome with renal insufficiency.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBranchio-Oto-Renal (BOR) syndrome is a multisystemic autosomal dominant disorder characterized by pre-auricular pits, hearing loss, branchial fistulae, and renal urinary tract malformations. Although renal involvement is common in BOR syndrome, studies on its renal pathological features remain relatively scarce. CASE PRESENTATION: An 18-year-old male presented with proteinuria, renal insufficiency, hearing loss, preauricular fistulas, and branchial fistulas. Imaging revealed small kidneys, and renal biopsy showed mild mesangial proliferative glomerular lesions, mild chronic tubulointerstitial injury with acute exacerbation. Electron microscopy demonstrated focal thinning of the glomerular basement membrane and segmental foot process effacement. Genetic testing identified a pathogenic variant (EYA1 c.1081 C > T p.Arg361*).
conclusionsThe clinical manifestations and severity of BOR syndrome are highly variable, making it prone to misdiagnosis or missed diagnosis. Genetic testing identified the pathogenic EYA1 variant in this case, and the pathological feature of focal thinning of the glomerular basement membrane was reported for the first time. This expanded the understanding of renal damage associated with this disease. For patients with unexplained renal insufficiency, detailed physical examination combined with genetic testing is necessary to improve the early diagnosis rate of BOR syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.